Sulfasalazine - Inflammatory bowel disease
You are here : Home > Formulary Search > Sulfasalazine - Inflammatory bowel disease
I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
Status 1
Amber
Formulations :
- Oral suspension
- Tablets
Formulary Status :
Associated Icons :
Restrictions / Comments :
Status 2
Amber
Formulations :
- Gastro-resistant tablets
Formulary Status :
Associated Icons :
Restrictions / Comments :
Important
Enteric coated tablets are significantly more expensive. Reserve for patients unable to tolerate plain tablets.
Status 3
Amber
Formulations :
- Suppositories
Formulary Status :
Associated Icons :
Restrictions / Comments :
Documentation
Shared Care
Shared Care
Shared Care
Shared Care
PAD Profile
ChemicalSubstance :
Sulfasalazine
Indication :
Inflammatory bowel disease
Group Name :
Keywords :
IBD, ulcerative colitis, UC, Crohn's disease
Brand Names Include :
Salazopyrin EN, sulazine
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
5
Traffic Light Entries :
3
Other Indications
Below are listed other indications that Sulfasalazine is used to treat.
Other Drugs
Below are listed other drugs that are used to treat Inflammatory bowel disease.
Committee Recommendations (2)
The Surrey Heartlands Integrated Care System Area Prescribing Committee have agreed a local adaptation of the National Shared Care document, in reference to the routine monitoring of CRP (rather than ESR) in primary care for inflammatory indications
The Surrey Heartlands Integrated Care System Area Prescribing Committee (APC) has agreed the National Shared Care Protocol (with local adaptations) for sulfasalazine for patients within adult services